Concepedia
Statistics
Publications
22
Citations
2K
H-Index
17
Active since
1987
Affiliations
Meiji Pharmaceutical University(Current)
Tokyo Institute of Technology
Nagasaki University
Meiji (Japan)
Aichi Cancer Center
Yoji Ikegami is an author at Meiji Pharmaceutical University specializing in medicine, pharmacology, and radiation oncology.
Top concepts
MedicinePharmacologyCell BiologyRadiation OncologyBiochemistryDrug ResistanceLung CancerCancer ResearchNatural SciencesBioanalysis
Publications per year
1987–2016
Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.
K Tanabe, Yoji Ikegami, Ryoji Ishida et al. · PubMed · 1991 · 297 citations
Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Chemistry +14
Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.
T Andoh, Kazuyuki Ishii, Yoshio Suzuki et al. · Proceedings of the National Academy of Sciences · 1987 · 288 citations · Full text
Chromatin, Genome Instability, Oncogenic Agent +14
Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells
Shigeru Kawabata, Mikio Oka, Ken Shiozawa et al. · Biochemical and Biophysical Research Communications · 2001 · 237 citations
Tumor Biology, Medicine, Cancer Cell Biology +8
Transport of 7-Ethyl-10-hydroxycamptothecin (SN-38) by Breast Cancer Resistance Protein ABCG2 in Human Lung Cancer Cells
Katsumi Nakatomi, Megumi Yoshikawa, Mikio Oka et al. · Biochemical and Biophysical Research Communications · 2001 · 187 citations
Tumor Biology, Medicine, Anti-cancer Agent +6
Gefitinib (“Iressa”, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses Breast Cancer Resistance Protein/ABCG2–Mediated Drug Resistance
Yoichi Nakamura, Mikio Oka, Hiroshi Soda et al. · Cancer Research · 2005 · 177 citations · Full text
1–5 of 22